Bisphenol A and bisphenol S both disrupt ovine granulosa cell steroidogenesis but through different molecular pathways.

Bisphenol Endocrine disruptors Ewe Granulosa cells Mechanisms of action Steroidogenesis

Journal

Journal of ovarian research
ISSN: 1757-2215
Titre abrégé: J Ovarian Res
Pays: England
ID NLM: 101474849

Informations de publication

Date de publication:
03 Feb 2023
Historique:
received: 29 07 2022
accepted: 29 01 2023
entrez: 4 2 2023
pubmed: 5 2 2023
medline: 8 2 2023
Statut: epublish

Résumé

Ovarian granulosa cells (GC) are essential for the development and maturation of a proper oocyte. GC are sensitive to endocrine disruptors, including bisphenol A (BPA) and its analogue bisphenol S (BPS), plasticisers present in everyday consumer products. BPA exhibits greater binding affinity for the membrane oestrogen receptor (GPER) than for the nuclear oestrogen receptors (ERα and ERβ). Here, we analysed the effects of BPA and BPS on the steroidogenesis of ovine GC in vitro, as well as their early mechanisms of action, the ovine being a relevant model to study human reproductive impairment. Disruption of GC steroidogenesis might alter oocyte quality and consequently fertility rate. In addition, we compared the effects of a specific GPER agonist (G-1) and antagonist (G-15) to those of BPA and BPS. Ewe GC were cultured with BPA or BPS (10 or 50 µM) or G-1 (1 µM) and/or G-15 (10 µM) for 48 h to study steroidogenesis. Both BPA and BPS (10 µM) altered the secretion of progesterone, however, only BPS (10 µM) affected oestradiol secretion. RNA-seq was performed on GC after 1 h of culture with BPA or BPS (50 µM) or G-1 (10 µM), followed by real-time PCR analyses of differentially expressed genes after 12, 24 and 48 h of culture. The absence of induced GPER target genes showed that BPA and BPS did not activate GPER in GC after 1 h of treatment. These molecules exhibited mainly independent early mechanisms of action. Gene ontology analysis showed that after 1 h of treatment, BPA mainly disrupted the expression of the genes involved in metabolism and transcription, while BPS had a smaller effect and impaired cellular communications. BPA had a transient effect on the expression of CHAC1 (NOTCH signalling and oxidative balance), JUN (linked to MAPK pathway), NR4A1 (oestradiol secretion inhibition), ARRDC4 (endocytose of GPCR) and KLF10 (cell growth, differentiation and apoptosis), while expression changes were maintained over time for the genes LSMEM1 (linked to MAPK pathway), TXNIP (oxidative stress) and LIF (cell cycle regulation) after 12 and 48 h, respectively. In conclusion, although they exhibited similar effects, BPA and BPS impaired different molecular pathways in GC in vitro. New investigations will be necessary to follow the temporal changes of these genes over time, as well as the biological processes involved.

Sections du résumé

BACKGROUND BACKGROUND
Ovarian granulosa cells (GC) are essential for the development and maturation of a proper oocyte. GC are sensitive to endocrine disruptors, including bisphenol A (BPA) and its analogue bisphenol S (BPS), plasticisers present in everyday consumer products. BPA exhibits greater binding affinity for the membrane oestrogen receptor (GPER) than for the nuclear oestrogen receptors (ERα and ERβ). Here, we analysed the effects of BPA and BPS on the steroidogenesis of ovine GC in vitro, as well as their early mechanisms of action, the ovine being a relevant model to study human reproductive impairment. Disruption of GC steroidogenesis might alter oocyte quality and consequently fertility rate. In addition, we compared the effects of a specific GPER agonist (G-1) and antagonist (G-15) to those of BPA and BPS. Ewe GC were cultured with BPA or BPS (10 or 50 µM) or G-1 (1 µM) and/or G-15 (10 µM) for 48 h to study steroidogenesis.
RESULTS RESULTS
Both BPA and BPS (10 µM) altered the secretion of progesterone, however, only BPS (10 µM) affected oestradiol secretion. RNA-seq was performed on GC after 1 h of culture with BPA or BPS (50 µM) or G-1 (10 µM), followed by real-time PCR analyses of differentially expressed genes after 12, 24 and 48 h of culture. The absence of induced GPER target genes showed that BPA and BPS did not activate GPER in GC after 1 h of treatment. These molecules exhibited mainly independent early mechanisms of action. Gene ontology analysis showed that after 1 h of treatment, BPA mainly disrupted the expression of the genes involved in metabolism and transcription, while BPS had a smaller effect and impaired cellular communications. BPA had a transient effect on the expression of CHAC1 (NOTCH signalling and oxidative balance), JUN (linked to MAPK pathway), NR4A1 (oestradiol secretion inhibition), ARRDC4 (endocytose of GPCR) and KLF10 (cell growth, differentiation and apoptosis), while expression changes were maintained over time for the genes LSMEM1 (linked to MAPK pathway), TXNIP (oxidative stress) and LIF (cell cycle regulation) after 12 and 48 h, respectively.
CONCLUSION CONCLUSIONS
In conclusion, although they exhibited similar effects, BPA and BPS impaired different molecular pathways in GC in vitro. New investigations will be necessary to follow the temporal changes of these genes over time, as well as the biological processes involved.

Identifiants

pubmed: 36737804
doi: 10.1186/s13048-023-01114-4
pii: 10.1186/s13048-023-01114-4
pmc: PMC9896735
doi:

Substances chimiques

bisphenol A MLT3645I99
Gonadal Steroid Hormones 0
Estradiol 4TI98Z838E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

30

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-18-CE34-0011-01

Informations de copyright

© 2023. The Author(s).

Références

J Dent. 2013 Aug;41(8):659-67
pubmed: 23643847
Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E385-91
pubmed: 18056793
Front Endocrinol (Lausanne). 2022 May 24;13:892213
pubmed: 35685208
Arch Toxicol. 2018 Apr;92(4):1581-1591
pubmed: 29380011
Gynecol Obstet Fertil. 2008 Sep;36(9):940-4
pubmed: 18707913
Mol Reprod Dev. 2008 May;75(5):904-14
pubmed: 17948250
Environ Toxicol Pharmacol. 2018 Apr;59:66-73
pubmed: 29544186
Biores Open Access. 2019 Oct 31;8(1):169-184
pubmed: 31681507
Fertil Steril. 2015 Nov;104(5):1116-26
pubmed: 26434804
Arch Biochem Biophys. 2017 Nov 1;633:29-39
pubmed: 28882636
J Steroid Biochem Mol Biol. 2016 Apr;158:9-21
pubmed: 26807866
Ecotoxicol Environ Saf. 2021 Jan 15;208:111429
pubmed: 33039870
Reprod Biol Endocrinol. 2021 Aug 3;19(1):119
pubmed: 34344364
Chemosphere. 2021 Jan;263:128304
pubmed: 33155548
Reprod Toxicol. 2011 Nov;32(3):304-12
pubmed: 21722727
Genes (Basel). 2021 Feb 23;12(2):
pubmed: 33672423
Int J Mol Sci. 2020 Aug 11;21(16):
pubmed: 32796699
Int J Environ Res Public Health. 2020 Apr 13;17(8):
pubmed: 32294918
Int J Mol Sci. 2020 Feb 12;21(4):
pubmed: 32059612
Int J Environ Res Public Health. 2021 Jan 15;18(2):
pubmed: 33467592
Anim Reprod Sci. 2018 May;192:91-98
pubmed: 29523361
Front Pharmacol. 2021 Feb 25;11:626448
pubmed: 33716730
Fertil Steril. 2016 Sep 15;106(4):857-63
pubmed: 27543890
J Cell Physiol. 2011 Jul;226(7):1820-7
pubmed: 21506113
Environ Health Perspect. 2012 Aug;120(8):1177-82
pubmed: 22552965
Chemosphere. 2019 Apr;220:185-194
pubmed: 30583211
Environ Res. 2019 Mar;170:406-415
pubmed: 30623888
Rocz Panstw Zakl Hig. 2021;72(1):49-53
pubmed: 33882786
Environ Res. 2019 Sep;176:108575
pubmed: 31299621
Reprod Domest Anim. 2018 Apr;53(2):450-457
pubmed: 29330967
Biol Reprod. 2009 Jan;80(1):34-41
pubmed: 18799753
Front Oncol. 2020 May 29;10:712
pubmed: 32670863
Oncotarget. 2017 Apr 11;8(15):25310-25322
pubmed: 28445976
Cells. 2019 Sep 21;8(10):
pubmed: 31546660
Diabetes Metab Syndr. 2021 May-Jun;15(3):803-811
pubmed: 33839640
Food Chem Toxicol. 2019 Sep;131:110575
pubmed: 31201899
BMC Pharmacol Toxicol. 2019 Jul 22;20(1):43
pubmed: 31331389
Chemosphere. 2018 May;199:182-190
pubmed: 29438945
Comp Biochem Physiol C Toxicol Pharmacol. 2021 Jun;244:109002
pubmed: 33610819
J Biol Regul Homeost Agents. 2018 Sep-Oct;32(5):1089-1103
pubmed: 30334402
Reproduction. 2013 May 21;145(6):555-65
pubmed: 23564726
Environ Sci Technol. 2020 Aug 18;54(16):10141-10148
pubmed: 32806918
Oncol Lett. 2022 May 18;24(1):217
pubmed: 35720489
Mol Hum Reprod. 2021 Sep 1;27(9):
pubmed: 34411256
Environ Sci Pollut Res Int. 2021 Jul;28(27):36060-36068
pubmed: 33683587
Sci Total Environ. 2021 Jun 25;775:145755
pubmed: 34132197
Toxics. 2020 Oct 21;8(4):
pubmed: 33096627
Hum Reprod. 2016 Jul;31(7):1562-9
pubmed: 27112698
Chemosphere. 2021 May;270:129445
pubmed: 33421752
BioData Min. 2019 Aug 6;12:16
pubmed: 31406507
Cytogenet Genome Res. 2015;145(1):50-8
pubmed: 25871885
Domest Anim Endocrinol. 2010 Jul;39(1):34-9
pubmed: 20172683
Cell Tissue Res. 2021 Sep;385(3):769-783
pubmed: 34008050
Int J Mol Sci. 2020 Mar 06;21(5):
pubmed: 32155818
Sci Total Environ. 2021 May 25;789:148013
pubmed: 34323825
Oncogene. 2015 Jun;34(25):3264-72
pubmed: 25151963
Reproduction. 2020 May;159(5):571-583
pubmed: 32092037
Environ Pollut. 2021 Oct 15;287:117671
pubmed: 34435562
Chemosphere. 2019 Aug;229:60-67
pubmed: 31075703
J Cell Physiol. 2009 Jan;218(1):26-31
pubmed: 18780287
Chemosphere. 2020 Aug;253:126707
pubmed: 32289607
Front Cell Dev Biol. 2021 Mar 23;9:661155
pubmed: 33834027
Transl Anim Sci. 2021 Apr 21;5(3):txab070
pubmed: 34377949
PLoS One. 2015 Nov 05;10(11):e0141482
pubmed: 26540452
Histochem Cell Biol. 2020 Jun;153(6):397-412
pubmed: 32157392
Domest Anim Endocrinol. 2019 Jan;66:48-56
pubmed: 30439591
Biomedicines. 2021 Jun 10;9(6):
pubmed: 34200822
Mol Cell Endocrinol. 2010 May 5;319(1-2):39-46
pubmed: 20083153
Environ Sci Technol. 2017 Sep 5;51(17):9940-9949
pubmed: 28759207
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
Reprod Domest Anim. 2003 Jun;38(3):209-13
pubmed: 12753555
Int J Mol Sci. 2022 May 26;23(11):
pubmed: 35682675
Animal. 2011 Mar;5(3):356-66
pubmed: 22445402
Mol Cell Endocrinol. 2008 Feb 13;283(1-2):12-8
pubmed: 18191889
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):175-9
pubmed: 17088055
Reprod Domest Anim. 2019 Jun;54(6):864-872
pubmed: 30972826
Nutrients. 2020 Feb 19;12(2):
pubmed: 32092919
Toxicol In Vitro. 2017 Dec;45(Pt 1):54-59
pubmed: 28811233
Mol Cell Endocrinol. 2018 Feb 5;461:55-63
pubmed: 28859904
Reprod Biomed Online. 2007 Jun;14(6):758-64
pubmed: 17579993
JBRA Assist Reprod. 2015 Nov 01;19(4):241-51
pubmed: 27203200

Auteurs

Ophélie Téteau (O)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France.

Anaïs Vitorino Carvalho (A)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France.

Pascal Papillier (P)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France.

Béatrice Mandon-Pépin (B)

INRAE, BREED, Université Paris-Saclay, UVSQ, 78350, Jouy-en-Josas, France.

Luc Jouneau (L)

INRAE, BREED, Université Paris-Saclay, UVSQ, 78350, Jouy-en-Josas, France.

Peggy Jarrier-Gaillard (P)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France.

Alice Desmarchais (A)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France.

Marie-Emilie Lebachelier de la Riviere (ME)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France.

Claire Vignault (C)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France.

Virginie Maillard (V)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France.

Aurélien Binet (A)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France.
Service de Chirurgie Pédiatrique Viscérale, Urologique, Plastique Et Brûlés, CHRU de Tours, 37000, Tours, France.

Svetlana Uzbekova (S)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France.

Sebastien Elis (S)

CNRS, IFCE, INRAE, Université de Tours, PRC, 37380, Nouzilly, France. sebastien.elis@inrae.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH